InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,701.74
(
-0.12%
)
US TECH 100
19,262.40
(
0.06%
)
Dow Jones
42,128.99
(
-0.07%
)
Brent Oil
73.85
(
-0.77%
)
Bitcoin
61,600.83
(
1.26%
)
Post# of 43375
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Fezziwig2008

Send PM Follow Ignore
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Fezziwig2008

Re: Fezziwig2008 post# 13911

Wednesday, 08/12/2020 9:05:47 AM

Wednesday, August 12, 2020 9:05:47 AM

Post# of 43375
Since direct anti IL-6 monoclonal antibodies -Actemra and Kevzara- failed - all that’s left for COVID ARDS therapy is the anti GM-CSF monoclonal antibody - HGEN Lenzilumab - snooze and lose.

https://www.biorxiv.org/content/10.1101/2020.02.12.945576v1
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up